Table 2. Remission of comorbidities at 1-year follow-up.
| Comorbidities | LRYGB | LSG | P value | ||
|---|---|---|---|---|---|
| Preoperative | Resolution or improvement (%) | Preoperative | Resolution or improvement (%) | ||
| T2DM | 21 | 17 (81.0) | 16 | 11 (68.8) | 0.46 a |
| Hypertension | 16 | 9 (56.3) | 17 | 7 (41.2) | 0.39 |
| Dyslipidemia | 36 | 21 (58.3) | 33 | 21 (63.6) | 0.65 |
| Hyperuricemia | 10 | 4 (40.0) | 12 | 4 (33.3) | >0.99 a |
| Sleep apnea | 15 | 10 (66.7) | 20 | 12 (60.0) | 0.69 |
LRYGB: laparoscopic Roux-en-Y gastric bypass; LSG: laparoscopic sleeve gastrectomy; T2DM: type 2 diabetes mellitus.
a
Fisher's exact test (two-sided).